Numorphan (Oxymorphone Hydrochloride) - Summary

NUMORPHAN SUMMARY

NUMORPHAN^®
(Oxymorphone Hydrochloride Injection, USP) CII
(Oxymorphone Hydrochloride Suppositories, USP)
Opioid
Analgesic

Rx only

NUMORPHAN (oxymorphone hydrochloride, USP), a semi-synthetic opioid substitute for morphine, is a potent analgesic.

NUMORPHAN Suppository is indicated for the relief of moderate to severe pain.

NUMORPHAN Injection is indicated for the relief of moderate to severe pain. It is also indicated for preoperative medication, for support of anesthesia, for obstetrical analgesia, and for relief of anxiety in patients with dyspnea associated with pulmonary edema secondary to acute left ventricular dysfunction.

NUMORPHAN NEWS HIGHLIGHTS

Media Articles Related to Numorphan (Oxymorphone)

Leading US Phase I Cancer Center Opens Site In Madrid, Spain - START Center For Cancer Care
Source: Cancer / Oncology News From Medical News Today [2008.10.06]

Pharmaleads' Lead Candidate For Pain, PL37, Enters Phase I
Source: Clinical Trials / Drug Trials News From Medical News Today [2008.10.04]

New Catheter-less Technique May Ease The Pain And Discomfort Of Prostate Cancer Recovery
Source: Prostate / Prostate Cancer News From Medical News Today [2008.10.03]

Is Your Child's Stomach Pain All In His Head?
Source: GastroIntestinal / Gastroenterology News From Medical News Today [2008.10.01]

Pain Is Not A Symptom Of Arthritis, Pain Causes Arthritis: New Study
Source: Arthritis / Rheumatology News From Medical News Today [2008.09.30]

more>>

Published Studies Related to Numorphan (Oxymorphone)

Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial. [2007.06]

Efficacy and Safety of OPANA ER (Oxymorphone Extended Release) for Relief of Moderate to Severe Chronic Low Back Pain in Opioid-Experienced Patients: A 12-Week, Randomized, Double-blind, Placebo-controlled Study. [2007.02]

A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. [2007.01]

A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. [2006.03]

Efficacy and safety of oxymorphone immediate release for the treatment of mild to moderate pain after ambulatory orthopedic surgery: results of a randomized, double-blind, placebo-controlled trial. [2005.12]

more>>

Clinical Trials Related to Numorphan (Oxymorphone)

A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation) [Recruiting]

Efficacy and Safety of Oxymorphone Immediate Release in Post-Surgical Acute Pain [Completed]

Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain [Completed]

Lumbar Stenosis Outcomes Research II [Recruiting]

Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-Malignant Pain [Completed]

more>>